Key learning on the promise and limitations of MRI in prostate cancer screening
Author:
Publisher
Springer Science and Business Media LLC
Link
https://link.springer.com/content/pdf/10.1007/s00330-024-10626-6.pdf
Reference30 articles.
1. Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660
2. Hugosson J, Roobol MJ, Månsson M et al (2019) A 16-yr follow-up of the European randomized study of screening for prostate cancer. Eur Urol 76:43–51. https://doi.org/10.1016/j.eururo.2019.02.009
3. Vickers A, O’Brien F, Montorsi F et al (2023) Current policies on early detection of prostate cancer create overdiagnosis and inequity with minimal benefit. BMJ 381:e071082. https://doi.org/10.1136/bmj-2022-071082
4. Van Poppel H, Roobol MJ, Chapple CR et al (2021) Prostate-specific antigen testing as part of a risk-adapted early detection strategy for prostate cancer: European Association of Urology Position and Recommendations for 2021. Eur Urol 80:703–711. https://doi.org/10.1016/j.eururo.2021.07.024
5. Eldred-Evans D, Tam H, Sokhi H et al (2020) Rethinking prostate cancer screening: could MRI be an alternative screening test? Nat Rev Urol 17:526–539. https://doi.org/10.1038/s41585-020-0356-2
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PI-QUAL version 2: A Multi-Reader reproducibility study on multiparametric MRI from a tertiary referral center;European Journal of Radiology;2024-12
2. Understanding the Barriers to Prostate Cancer Population-Based Early Detection Programs: The PRAISE-U BEST Survey;Journal of Personalized Medicine;2024-07-15
3. PI-QUAL version 2: the radiologist’s perspective;European Radiology;2024-06-24
4. Refining clinical decision strategies and prostate cancer detection through fine adjustments in the combination of PSA-derived parameters and MRI;European Radiology;2024-04-29
5. Multiparametric MRI for characterization of the tumour microenvironment;Nature Reviews Clinical Oncology;2024-04-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3